Document/ExhibitDescriptionPagesSize 1: 8-K/A Amendment to Current Report HTML 27K
6: R1 Cover HTML 45K
8: XML IDEA XML File -- Filing Summary XML 11K
11: XML XBRL Instance -- unh-20240328_htm XML 14K
7: EXCEL IDEA Workbook of Financial Report Info XLSX 8K
3: EX-101.DEF XBRL Definitions -- unh-20240328_def XML 38K
4: EX-101.LAB XBRL Labels -- unh-20240328_lab XML 71K
5: EX-101.PRE XBRL Presentations -- unh-20240328_pre XML 38K
2: EX-101.SCH XBRL Schema -- unh-20240328 XSD 10K
9: JSON XBRL Instance as JSON Data -- MetaLinks 13± 19K
10: ZIP XBRL Zipped Folder -- 0000731766-24-000148-xbrl Zip 16K
Registrant’s telephone number, including area code: (i952) i936-1300
N/A
(Former name or former address, if changed since last report.)
—————————————
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
i☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
iCommon
Stock, $.01 par value
iUNH
iNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
i☐Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Explanatory
Note
This Amendment No. 1 (the “Amendment”) amends the Current Report on Form 8-K filed by UnitedHealth Group Incorporated (the “Company”) with the Securities and Exchange Commission on March 28, 2024 (the “Original Report”).
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As an update to the Original Report, the Company’s Compensation and Human Resources Committee has approved compensation to Mr. Rex consisting of an annual base salary of $1,400,000 and an annual cash incentive award opportunity that has a target
value of 200% of his base salary.Additionally, the Company’s Compensation and Human Resources Committee has approved grants of stock awards to Mr. Rex consisting of stock options with a value of $150,000, restricted stock units with a value of $150,000 and performance shares with a value of $300,000. Other aspects of Mr. Rex’s compensation were not affected.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
